Abstract submission

The newcomer abstract provides an opportunity for newcomers to present their research and to receive feedback from more experienced researchers in the field. Eligible individuals can submit an abstract of original research related to pharmacoepidemiology, and if accepted, will present their work as an oral or poster presentation during the conference.

The aim is to provide a platform for newcomers to showcase their work, gain experience in presenting their research, and receive feedback from experienced researchers in the field.

When evaluating newcomer abstracts, reviewers will provide comments and suggestions to authors on their first submission, allowing them to update their abstract and resubmit before the abstract submission deadline.

Criteria for newcomer abstract submission

To be eligible to submit an abstract under the Newcomer abstract, you must be:

• Student: Individuals who are currently enrolled in an undergraduate, graduate, and/or doctoral research program (early years) in pharmacoepidemiology or a related field.
• Early career researcher: Researchers who have recently completed their PhD or postdoctoral fellowship in pharmacoepidemiology or a related field and are in the early stages (< 2 years) of their career.
• Low-income and middle-income country researcher: Researchers who are from low-income and middle-income countries and who are in the early stages of their career (< 3 years).
• First-time presenter: Researchers who have not previously presented at an international conference.
• Junior faculty: Researchers who are in the early stages of their faculty career.

Research abstracts are eligible, whether or not their content has been presented at meetings of other scientific societies, as long as they meet the following criteria:

• relevant to the field of pharmacoepidemiology as broadly defined
• results have not been published (except in abstract form) either on-line or in printed full form before January 1 of the year of the meeting, and
• results have not been presented at a previous ISPE meeting.

Oral presentation:

15 minutes (10 minutes for presentation and 5 minutes questions). Presenting in-person.

Poster presentation: 

Presenters will print an A0 (1189 mm high x 841 mm wide) size poster to display in the poster gallery and must be in attendance at their poster at a specific time to discuss with interested attendees. Presenting in-person.

Spotlight Posters: 

A number of notable posters will be pre-selected for the Spotlight Poster Session. These poster presenters will be invited to deliver a 4-minute oral description of their work in English, followed by audience discussions moderated by a senior ISPE member. No slides can be used in describing the work, and the 4-minute time limit will be strictly enforced. Successful presenters will be notified on Monday 14 September 2026.

Topics for abstract submission are:

A. Benefit-Risk Assessment, Communication and Evaluation (BRACE)
B. Biologics / Biosimilars
C. Disease Epidemiology / Clinical Course
D. Drug Effectivenesse
E. Drug Utilization Research
F. Environmental Pharmacoepidemiology
G. Geriatric Pharmacoepidemiology
H. Health Economics / Outcomes Research
I. Health Equity
J. Artificial Intelligence / Informatics / Digital Epidemiology
K. Methods in Pharmacoepidemiology
L. Molecular Epidemiology / Biomarkers / Pharmacogenetics
M. Medical Devices
N. Pediatric Pharmacoepidemiology
O. Pharmacovigilance
P. Pharmacy Practice and Pharmacoepidemiology
Q. Pregnancy and Lactation
R. Rare Disease
S. Safety Outcomes
T. Traditional and Alternative Medicines
U. Vaccines
V. Other related fields

Abstract title

• Should be concise and clearly describe your study.
• Must not exceed 12 words.
• Only capitalise the first letter of the first word in the title, like you would in a sentence, and any proper nouns such as Countries or project names. 
• Do not use full stops in the title.

Author names and affiliations

• Up to 15 authors and affiliations may be included on each abstract. All authors must have consented to the abstract submission.

Abstract text

• Must not exceed 300 words (excluding the Title, Authors, and Affiliations).
• Do not enter the abstract title or authors’ details in this section.
• Do not reference institution names, locations, graphics, tables or funding sources in the abstract.
• Graphics and tables cannot be submitted as part of your abstract.
• Start the sentences for each heading on the same line as the heading

Abstracts should include the following headings:

Introduction: (3-4 sentences)

• Briefly describe the context and importance of your research question or hypothesis.
• State the specific problem addressed.

Aims: (2 sentences)

• Clearly stated research objective.

Methods: (3-4 sentences)

• Describe your study design, participants/samples, data collection procedures, and analytical approach.
• Include relevant dates, locations, and eligibility criteria as applicable.

Results: (5-7 sentences)

• Present your main findings with appropriate data (percentages, means, p-values, etc.).
• Be specific and quantitative rather than general.

Conclusions: (2-3 sentences)

• Summarize the main implications of your findings and their significance to the field.
• You may include recommendations or suggestions for future research.

Keywords: Provide 3 keywords or phrases that will help in the indexing of your abstract.

All submitted abstracts will be reviewed by at least 5 reviewers.

When evaluating each abstract, reviewers will be unaware of authors or institutions involved with the work described in the abstract. (Abstracts will be suitably anonymised by the program secretariat before being sent out to reviewers).

When evaluating newcomer track abstracts, reviewers will provide comments and suggestions to authors on their first submission, allowing them to update their abstract and resubmit before the abstract submission deadline.

The Program Committee will assign accepted abstracts either to oral or poster presentation, and the reviewers’ decision is final.

The Organising Committee reserves the right to accept or decline any submissions and to select the presentation format.

Presenting authors will be notified of their acceptance status on Monday 27 July 2026 and must inform any co-author(s).

Presenter Registration

All presenting authors must have registered and paid to attend the conference by Friday 21 August 2026.

Accepted abstracts will be published in the conference program only if the presenting author has registered for the conference.